CN111437360A - Cancer-eliminating yang-strengthening plaster - Google Patents
Cancer-eliminating yang-strengthening plaster Download PDFInfo
- Publication number
- CN111437360A CN111437360A CN202010363678.1A CN202010363678A CN111437360A CN 111437360 A CN111437360 A CN 111437360A CN 202010363678 A CN202010363678 A CN 202010363678A CN 111437360 A CN111437360 A CN 111437360A
- Authority
- CN
- China
- Prior art keywords
- parts
- yang
- raw
- cancer
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Insects & Arthropods (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Animal Husbandry (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a cancer-eliminating and yang-supporting paste, which belongs to the technical field of traditional Chinese medicines, mainly adopts warm traditional Chinese medicines, and has good curative effects on removing focus of infection and relieving pain by mutually combining yang-supporting to change yang deficiency, changing physique and attacking and eliminating pathogenic factors, strengthening body resistance to strengthen gasification function, yang-supporting, cold-warming, dampness-resolving and blood stasis-removing, blood circulation-promoting and blood stasis-removing, qi-regulating and pain-relieving and the like.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a cancer-eliminating and yang-supporting patch.
Background
Currently, cancer has dominated the disease with the highest mortality rate in humans, which engulfs human life in millions of numbers per year. Although medical science is developed more and more, there is no great progress in the cure rate of cancer for a long time, and at present, radiotherapy and chemotherapy, which are commonly used, treat tumors by throttling the nutrition provided to the cancer, thereby shrinking the cancer. Chemotherapy is carried out to fill toxin in human body, and normal cells are killed while cancer cells are killed, so that the tumor eliminating human body is at the edge of death. While radiotherapy kills cancer cells with various rays and also kills normal cells and energy channels supplying energy to tumors, so that the channels are blocked, and the tumors are shrunk or disappeared, radiotherapy has no choice, and kills the energy supply channels supplying energy to the tumors and also destroys many normal energy supply paths in a human body, so that new tumors are generated in other places of the human body, which is the so-called cancer cell diffusion and metastasis in modern medicine.
From the traditional Chinese medicine, yang qi is the foundation of life, and cancer treatment can also be performed by surgical resection, but the surgery has great harm to human body, particularly damages yang qi, and causes yang qi deficiency and pathogenic factors to repeat. Tumor with obvious negative disease. Firstly, only people with constitution of three yin may develop tumor, and the most obvious feature of constitution of three yin is insufficiency of yang qi, which cannot form effective resistance to yin pathogen. Therefore, pathogenic qi invades three yin regions and forms a lump at the most weak part of the body where the yang qi is weakened. From a biological point of view, cell differentiation, apoptosis are related to cell executive functions, belonging to "positive qi", cell proliferation is related to cell number, body growth, belonging to "negative shaping", and dysplasia, uncontrolled proliferation, differentiation disorders, and apoptosis repression are the basic biological characteristics of tumors, leukemias. Therefore, the essence of the tumor is insufficient yang-qi and accumulation of yin-cold. The treatment of tumor needs to change the constitution of yang deficiency,
the book of Nei Jing says: wind-cold and all diseases are always beginning to occur in the skin and hair. The pathogenic factors invade the skin and hair striae and the striae open to enter the collaterals, so that the meridian-qi will be full of the pathogenic factors and enter the meridians, and finally the meridian-qi will invade the zang-fu organs to cause the disease. The doctors who are good at treating the diseases always treat the skin and hair firstly, then treat the skin, secondly treat the channels and collaterals, secondly treat the six fu-organs and finally treat the five internal organs. If five zang organs are treated first, half of the life and death will occur. Therefore, the external treatment should first identify yin and yang, then identify the zang-fu organs, so that the meridians and collaterals of the zang-fu organs correspond to each other, and the zang-fu organs are closely related to the zang-viscera, zang-viscera and fu-viscera through meridians and collaterals, and the zang-viscera, blood, essence and body fluids are connected to the zang-viscera, zang-viscera and fu-viscera, so as to form an organic whole.
The application history of the plaster in China is long, and ancient medicine says that the plaster can cure diseases and has no special decoction, and the plaster responds with a response. The plaster is a big compound of a plurality of medicines by applying the principle of Chinese medicine channel tropism and the efficiency of mutually coordinating the medicines so as to exert the good effect of the medicines. The advantages and disadvantages of the plaster are fundamental. The plaster belongs to external treatment, thereby avoiding the toxic and side effects of oral medicines, and being widely popular with the masses due to definite curative effect. The Qing Dynasty Xuda Chun is recorded in the name of: for the deficiency of the decoction, the plaster should be used to block the qi, so that the property of the drug can enter into the skin and skin striae from the pores, clear and activate the meridians, or be extracted or dispersed, which is more powerful than the herb. The medicine in the plaster is directly pasted on the body surface acupuncture points, the medicine property penetrates through skin and hair striae from the outside to the inside and permeates to subcutaneous tissues, and on one hand, the relative advantage of the medicine concentration is generated locally; on the other hand, the medicine can reach the disease of viscera failing to regulate menstruation and qi disorder through the through and running of meridians, and can play the role of medicine 'meridian tropism' and functional effect, thereby playing the maximum pharmacological effect of the whole body. In addition to the damage to the nervous, vascular and muscular tissues and the intestinal reactions and the poor acceptance of patients, the traditional injection and oral therapies are easy to cause the medicines to pass through the blood circulation of the whole body and the intestinal damage, so that the medicines really reaching the local parts of the diseases are very little, the dosage is very large, and the curative effect is very poor. The plaster can be used for external treatment to solve the problem, and the medicine can directly act on affected parts to improve the drug effect by several times and prevent drug resistance.
Disclosure of Invention
In view of the above problems, the present invention aims to provide a cancer-eliminating yang-supporting plaster, which mainly adopts warm traditional Chinese medicines to support yang to change yang deficiency, change physique and attack pathogenic factors, combines the functions of supporting healthy energy to strengthen qi transformation, supporting yang, warming cold, eliminating dampness and removing stasis, promoting blood circulation and removing stasis, regulating qi to alleviate pain, etc., and has good curative effects on eliminating focus of infection and relieving pain.
In order to achieve the purpose, the invention adopts the specific scheme that:
a plaster for eliminating cancer and strengthening yang comprises a component A and a component B;
the component A comprises the following components in parts by weight: 55-65 parts of unprocessed nux vomica, 45-55 parts of unprocessed radix aconiti kusnezoffii, 45-55 parts of unprocessed radix aconiti, 25-35 parts of euphorbia kansui, 45-55 parts of datura flower, 55-65 parts of paris polyphylla, 25-35 parts of grub, 25-35 parts of unprocessed semen brassicae, 40-50 parts of unprocessed myrrh, 25-35 parts of pseudo-ginseng powder, 25-35 parts of dragon's blood, 25-35 parts of flos caryophyllata, 40-50 parts of asarum, 25-35 parts of sal ammoniac, 55-65 parts of unprocessed arisaema tuber, 45-55 parts of unprocessed rhizoma pinelliae, 40-50 parts of realgar, 8-12 parts of centipede, 25-35 parts of scorpion, 15-25 parts of toad, 15-25 parts of camphor, 40-50 parts of borneol and 1-5 parts of musk;
the component B comprises the following components in parts by weight: 85-95 parts of iron leaf, 85-95 parts of rhizoma sparganii, 85-95 parts of curcuma zedoary, 85-95 parts of pollen, 55-65 parts of rice husk, 55-65 parts of zaocys dhumnade, 55-65 parts of clematis root, 55-65 parts of spina gleditsiae, 55-65 parts of salvia miltiorrhiza, 55-65 parts of akebia fruit, 55-65 parts of ephedra, 55-65 parts of cassia twig, 55-65 parts of caulis spatholobi, 55-65 parts of peach kernel, 55-65 parts of fructus kochiae, 55-65 parts of radix sophorae flavescentis, 55-65 parts of campsis grandiflora, 55-65 parts of cocklebur fruit, 55-65 parts of magnolia flower, 55-65 parts of tribulus terrestris, 45-55 parts of radix angelicae, 45-55 parts of curcuma longa, 45-55 parts of safflower, 45-55 parts of angelica sinensis, 45-55 parts of ligusticum wallichii, 45-, 55-65 parts of earthworm, 55-65 parts of garden balsam stem, 55-65 parts of golden cypress, 55-65 parts of rhizoma kaempferiae, 25-35 parts of raw rhizoma corydalis and 40-50 parts of dragon's bone.
As a further optimization of the scheme, the component A comprises the following components in parts by weight: 60 parts of raw nux vomica, 50 parts of raw kusnezoff monkshood root, 50 parts of raw common monkshood mother root, 30 parts of euphorbia kansui, 50 parts of datura flower, 60 parts of paris polyphylla, 30 parts of grub, 30 parts of raw white mustard seed, 45 parts of raw myrrh, 30 parts of pseudo-ginseng powder, 30 parts of dragon's blood, 30 parts of flos caryophyllata, 45 parts of asarum liaotungensis, 30 parts of sal ammoniac, 60 parts of raw arisaema tuber, 50 parts of raw pinellia tuber, 45 parts of realgar, 10 parts of centipede, 30 parts of scorpion, 20 parts of toad, 20 parts of camphor, 45 parts of borneol and 3;
the component B comprises the following components in parts by weight: 90 parts of iron tree leaves, 90 parts of rhizoma sparganii, 90 parts of curcuma zedoary, 90 parts of pollen, 60 parts of rice husks, 60 parts of garter snake, 60 parts of clematis chinensis, 60 parts of spina gleditsiae, 60 parts of salvia miltiorrhiza, 60 parts of fiveleaf akebia fruit, 60 parts of ephedra, 60 parts of cassia twig, 60 parts of suberect spatholobus stem, 60 parts of peach kernel, 60 parts of belvedere fruit, 60 parts of lightyellow sophora root, 60 parts of campsis grandiflora, 60 parts of cocklebur fruit, 60 parts of magnolia flower, 60 parts of tribulus terrestris, 50 parts of angelica dahurica, 50 parts of turmeric, 45 parts of safflower, 50 parts of angelica, 50 parts of ligusticum wallichii, 50 parts of radix rehmanniae, 50 parts of fructus aurantii, 60 parts of earthworm, 60 parts of garden balsam.
The invention also provides a preparation method of the cancer-eliminating and yang-strengthening paste, which comprises the following steps:
step one, weighing the raw materials of the component A according to the parts by weight of the raw materials, mixing, and grinding into 100-mesh fine powder to obtain powder A for later use;
step two, weighing and mixing the raw materials according to the weight parts of the raw materials of the component B to obtain a mixture; decocting the mixture with water twice, wherein the time for decocting with water is at least 1h each time; mixing the decoctions, and sieving with 100 mesh sieve to obtain filtrate; concentrating the filtrate into fluid extract for later use;
step three, weighing plaster matrixes, melting the plaster matrixes with slow fire, then removing the fire, cooling the plaster matrixes to 65-75 ℃, continuously stirring the plaster matrixes in the cooling process, slowly adding the fluid extract obtained in the step two, stirring the fluid extract uniformly, and then continuously heating the fluid extract with slow fire to remove water; and (3) cooling to 65-75 ℃ with fire, adding the powder A obtained in the step (I), and continuously stirring to spread paste to obtain the cancer-eliminating and yang-strengthening paste.
Has the advantages that:
the plaster is applied to the pain part of the focus, on one hand, the medicine can be directly absorbed through skin, orifices, acupuncture points and the like, enters channels and collaterals, and is distributed to the whole body to play a pharmacological role, and on the other hand, the medicine can stimulate the local part and play a role in correcting the abundance and insufficiency of qi, blood, yin and yang of viscera through the regulation of the channels and collaterals system. Thereby achieving the purposes of well eliminating focus and relieving pain.
The cancer-eliminating yang-restoring plaster aims at positioning the 'yin forming' of tumors to strengthen yang and change yang deficiency, mainly adopts warm traditional Chinese medicines, combines constitution changing and pathogenic factor attacking, and strengthens body resistance to strengthen gasification function. The tumor is caused by decline of fire from the gate of life, belongs to cold phlegm coagulation, and has the effects of strengthening yang, warming cold, eliminating dampness, removing blood stasis, etc. the cold dampness removes the yang-qi, and the tumor dissipates naturally. Secondly, cancer patients are often accompanied with cancer pain, and mainly cold pathogen is condensed at the pain part to cause qi and blood obstruction, meridian obstruction and qi and blood failing to nourish the pain, so as to activate blood circulation to dissipate blood stasis, regulate qi and alleviate pain to treat cancer pain. The medicine used by the cancer-eliminating yang-strengthening paste disclosed by the invention has the functions of benefiting yang and tonifying qi, eliminating yin cold, tonifying deficiency and rectifying deviation, and can be used for treating insufficient yang qi and delayed pulse, so that the effect can be obtained. In addition, asarum, musk, cassia twig, angelica dahurica and the like are used for warming yang and dispelling cold to relieve pain with warm, scorpion, centipede, earthworm and the like are used for dredging collaterals to relieve pain, toad is used for detoxifying and relieving pain, pinellia ternata for generating drought is used for reducing phlegm and resolving masses, salvia miltiorrhiza, turmeric and the like are used for relieving pain with slow and quick action, clove, musk and other smells are pungent and fragrant to walk away, so that the medicines can penetrate through skin and reach the focus, other medicines can be harmonized to enhance the effect of warming and activating, the medicines are introduced into the interior, the effective pain relieving effect can be achieved on cancer pain, the pain relieving duration is long, and abdominal distension, constipation and anorexia caused by morphine type analgesics.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention.
Example 1
A plaster for eliminating cancer and strengthening yang comprises a component A and a component B; wherein, the component A comprises: 60g of raw nux vomica, 50g of raw kusnezoff monkshood root, 50g of raw common monkshood mother root, 30g of euphorbia kansui, 50g of datura flower, 60g of paris polyphylla, 30g of grub, 30g of raw white mustard seed, 45g of raw myrrh, 30g of pseudo-ginseng powder, 30g of dragon's blood, 30g of flos caryophyllata, 45g of asarum liaotungensis, 30g of sal ammoniac, 60g of raw arisaema consanguineum, 50g of raw pinellia ternate, 45g of realgar, 10g of centipede, 30g of scorpion, 20g of toad, 20g of camphor, 45 g.
The component B comprises: 90g of folium aconiti szechenyiani, 90g of rhizoma sparganii, 90g of curcuma zedoary, 90g of pollen, 60g of rice husk, 60g of zaocys dhumnades, 60g of radix clematidis, 60g of spina gleditsiae, 60g of salvia miltiorrhiza, 60g of fiveleaf akebia fruit, 60g of ephedra, 60g of cassia twig, 60g of caulis spatholobi, 60g of peach kernel, 60g of fructus kochiae, 60g of radix sophorae flavescentis, 60g of campsis grandiflora, 60g of cocklebur fruit, 60g of magnolia flower, 60g of tribulus terrestris, 50g of radix angelicae, 50g of curcuma longa, 45g of safflower carthamus, 50g of angelica sinensis, 50g of ligusticum wallichii, 50g of radix rehmanniae, 50g of fructus aurantii.
The production process comprises the following steps:
1. mixing the raw materials of the component A, and grinding into 100-mesh fine powder to obtain powder A for later use;
2. mixing the raw materials of the component B, decocting with water twice, each time for more than 1 hour, mixing the two liquid medicines, filtering with a 100-mesh sieve, and concentrating the filtrate into fluid extract for later use. Weighing 3600g of plaster matrix, melting with slow fire, removing the fire, cooling the matrix to about 70 ℃, slowly adding the fluid extract under continuous stirring, completely stirring uniformly, continuing heating with slow fire to remove water vapor, removing the fire, and cooling to about 70 ℃ to add the powder A. After stirring for two hours, spreading the paste. The prepared plaster is packaged, sealed and placed in a shade for storage.
Example 2
A plaster for eliminating cancer and strengthening yang comprises a component A and a component B; wherein, the component A comprises: 70g of raw nux vomica, 60g of raw kusnezoff monkshood root, 40g of raw common monkshood mother root, 40g of euphorbia kansui, 60g of datura flower, 70g of paris polyphylla, 40g of grub, 40g of raw white mustard seed, 55g of raw myrrh, 40g of pseudo-ginseng powder, 40g of dragon's blood, 40g of flos caryophyllata, 55g of asarum liaotungensis, 40g of sal ammoniac, 70g of raw arisaema consanguineum, 60g of raw pinellia ternate, 55g of realgar, 15g of centipede, 40g of scorpion, 30g of toad, 30g of camphor, 55 g.
The component B comprises: 80g of iron leaf, 80g of rhizoma sparganii, 80g of curcuma zedoary, 80g of pollen, 50g of rice husk, 50g of zaocys dhumnade, 50g of radix clematidis, 50g of spina gleditsiae, 50g of salvia miltiorrhiza, 50g of fiveleaf akebia fruit, 50g of ephedra, 50g of cassia twig, 50g of suberect spatholobus stem, 50g of peach kernel, 50g of belvedere fruit, 50g of radix sophorae flavescentis, 50g of campsis grandiflora, 50g of cocklebur fruit, 50g of magnolia flower, 50g of tribulus terrestris, 40g of radix angelicae, 40g of turmeric, 35g of safflower carthamus, 40g of angelica sinensis, 40g of ligusticum wallichii, 40g of radix rehmanniae, 40g of fructus aurantii, 50g of earthworm, 50.
The cancer-eliminating yang-recovering plaster of the invention is mainly used for treating: liver cancer, lung cancer, esophagus cancer, stomach cancer, pancreatic cancer and the like, and also has obvious curative effect on liver cirrhosis.
The using method comprises the following steps: the patch is applied to the affected part after heating, and each patch is applied for 5-7 days.
Note that: 1. external products, no oral administration. 2. The product has no side effect generally, and should be used with cautions for allergic constitution. 3. Is arranged at a place which is not easy to be reached by children. 4. The plaster residues are dipped in cotton swab to scrub with small grinding oil.
And (3) evaluating the effect:
the patients with advanced malignant tumor are selected from 30 patients, and confirmed to be diagnosed by pathological examination, X-ray film, B-ultrasonic examination, CT examination, laboratory examination, etc., wherein 18 men and 12 women are aged 33-79 years old, and the number of the middle-aged and the elderly is large. Including liver cancer 5, lung cancer 6, esophageal cancer 4, stomach cancer 7, lymph cancer 3 cases, pancreatic cancer 1 case, uterine cancer 1 case, and other cancers 3 cases. 11 cases with a tumor diameter of less than 3cm, 10 cases with a diameter of 3-5 cm, 6 cases with a diameter of 5-7 cm, and 3 cases with a diameter of 7-10 cm.
The treatment method comprises the following steps: the plaster is applied to the parts with severe pain after being heated, the application area is appropriate according to the pain range, and the application area is generally 2-4cm larger than the tumor body.
The therapeutic effect judgment standard is judged from two aspects of lesion change and pain relief degree. The method comprises the following specific steps:
lesion change determination criteria: according to the therapeutic standard of solid tumor established by the world health organization in 1979. And (3) complete alleviation: the focus seen before treatment completely disappears, and no new lesion appears; partial mitigation: the lesion has been narrowed to 50% or less before treatment, and no new lesions appear; no change: the area of the focus is reduced by less than 50 percent; expanding: the total area of a single focus or the area of a plurality of focuses is increased by 25 percent or more than before treatment, or new lesions appear. The results are shown in Table 1.
Criteria for pain reduction determination: the effect is shown: the pain of the patient disappears or is obviously relieved after the medicine is taken; the method has the following advantages: pain is relieved after administration; and (4) invalidation: the pain was not relieved after administration. The results are shown in Table 2.
Table 1: and (5) judging the change of the focus.
Therapeutic effect | Complete relief | Partial relief | Without change | Extension |
Number n | 10 | 12 | 8 | 0 |
Table 2: the degree of pain relief results.
Therapeutic effect | Show effect | Is effective | Invalidation |
Number n | 28 | 1 | 1 |
As can be seen from the above tables 1 and 2, the cancer-eliminating yang-supporting patch of the present invention can control the disease condition of patients with advanced cancer, the complete remission rate of the disease focus can reach 33.3%, the remission rate can reach 73.3%, and the present invention has no obvious toxic and side effects on the patients and can not cause new diseases. Most obviously, the pain caused by pathological changes of patients with advanced tumors can be effectively relieved, and the living standard of the patients is effectively improved.
Typical cases are:
case 1: in a certain area, men are diagnosed as late esophagus cancer in 69 years and in 16 years in 6 months, the patients are diagnosed in early period in each hospital, no effective treatment method is available in consideration of the older age, the patients are returned to home for recuperation, then the cancer-eliminating and yang-strengthening paste is used, the pain is well relieved, the disease condition is well controlled after about seven months of treatment, the people are fat, spirited, and have repeated diagnosis, the pulse is tight, and the tongue coating is smooth.
Case 2: lie, female, age 79, western diagnosis: lung cancer. Continuously applying the anti-cancer yang-strengthening paste for two months, mainly complaining: cough and asthma can promote the improvement of symptoms, little phlegm has no blood streak, and the spirit is improved. Four diagnosis: a dark-red tongue with white and greasy coating and yellow coating, and a slippery and rapid pulse.
Case 3: some of the week, female, age 54, diagnosis in western medicine: lung cancer, the diseased region can not be operated, and has not been treated with radiotherapy and chemotherapy, but has been treated with pleural effusion. The main complaints are: cough with white and thick sputum with blood streaks, phlegm obstruction, chest distress, pain, aversion to cold. The continuous application of the plaster for eliminating cancer and strengthening yang can lead the tongue to be reddish, the coating to be thin, yellow and slightly greasy, the pulse to be smooth, the chest distress and the chest pain to disappear after two months.
Case 4: wu Chi, male, 61 years old, suffered from hepatitis B virus carrying in young, was diagnosed in the middle of cirrhosis in 11 months of 17 years, had taken the drugs of compound amiloride hydrochloride tablets and the like, the abdominal pain was not obviously relieved, the life was seriously affected, the abdominal pain was obviously relieved when the compound amiloride hydrochloride tablets were applied to the abdomen, and the abdominal pain disappeared after two weeks of continuous use.
It should be noted that the above-mentioned embodiments illustrate rather than limit the scope of the invention, which is defined by the appended claims. It will be apparent to those skilled in the art that certain insubstantial modifications and adaptations of the present invention can be made without departing from the spirit and scope of the invention.
Claims (3)
1. The utility model provides a subsides of cancer elimination and strengthening yang which characterized in that: comprises a component A and a component B;
the component A comprises the following components in parts by weight: 55-65 parts of unprocessed nux vomica, 45-55 parts of unprocessed radix aconiti kusnezoffii, 45-55 parts of unprocessed radix aconiti, 25-35 parts of euphorbia kansui, 45-55 parts of datura flower, 55-65 parts of paris polyphylla, 25-35 parts of grub, 25-35 parts of unprocessed semen brassicae, 40-50 parts of unprocessed myrrh, 25-35 parts of pseudo-ginseng powder, 25-35 parts of dragon's blood, 25-35 parts of flos caryophyllata, 40-50 parts of asarum, 25-35 parts of sal ammoniac, 55-65 parts of unprocessed arisaema tuber, 45-55 parts of unprocessed rhizoma pinelliae, 40-50 parts of realgar, 8-12 parts of centipede, 25-35 parts of scorpion, 15-25 parts of toad, 15-25 parts of camphor, 40-50 parts of borneol and 1-5 parts of musk;
the component B comprises the following components in parts by weight: 85-95 parts of iron leaf, 85-95 parts of rhizoma sparganii, 85-95 parts of curcuma zedoary, 85-95 parts of pollen, 55-65 parts of rice husk, 55-65 parts of zaocys dhumnade, 55-65 parts of clematis root, 55-65 parts of spina gleditsiae, 55-65 parts of salvia miltiorrhiza, 55-65 parts of akebia fruit, 55-65 parts of ephedra, 55-65 parts of cassia twig, 55-65 parts of caulis spatholobi, 55-65 parts of peach kernel, 55-65 parts of fructus kochiae, 55-65 parts of radix sophorae flavescentis, 55-65 parts of campsis grandiflora, 55-65 parts of cocklebur fruit, 55-65 parts of magnolia flower, 55-65 parts of tribulus terrestris, 45-55 parts of radix angelicae, 45-55 parts of curcuma longa, 45-55 parts of safflower, 45-55 parts of angelica sinensis, 45-55 parts of ligusticum wallichii, 45-, 55-65 parts of earthworm, 55-65 parts of garden balsam stem, 55-65 parts of golden cypress, 55-65 parts of rhizoma kaempferiae, 25-35 parts of raw rhizoma corydalis and 40-50 parts of dragon's bone.
2. The cancer-eliminating yang-strengthening paste as claimed in claim 1, wherein: the component A comprises the following components in parts by weight: 60 parts of raw nux vomica, 50 parts of raw kusnezoff monkshood root, 50 parts of raw common monkshood mother root, 30 parts of euphorbia kansui, 50 parts of datura flower, 60 parts of paris polyphylla, 30 parts of grub, 30 parts of raw white mustard seed, 45 parts of raw myrrh, 30 parts of pseudo-ginseng powder, 30 parts of dragon's blood, 30 parts of flos caryophyllata, 45 parts of asarum liaotungensis, 30 parts of sal ammoniac, 60 parts of raw arisaema tuber, 50 parts of raw pinellia tuber, 45 parts of realgar, 10 parts of centipede, 30 parts of scorpion, 20 parts of toad, 20 parts of camphor, 45 parts of borneol and 3;
the component B comprises the following components in parts by weight: 90 parts of iron tree leaves, 90 parts of rhizoma sparganii, 90 parts of curcuma zedoary, 90 parts of pollen, 60 parts of rice husks, 60 parts of garter snake, 60 parts of clematis chinensis, 60 parts of spina gleditsiae, 60 parts of salvia miltiorrhiza, 60 parts of fiveleaf akebia fruit, 60 parts of ephedra, 60 parts of cassia twig, 60 parts of suberect spatholobus stem, 60 parts of peach kernel, 60 parts of belvedere fruit, 60 parts of lightyellow sophora root, 60 parts of campsis grandiflora, 60 parts of cocklebur fruit, 60 parts of magnolia flower, 60 parts of tribulus terrestris, 50 parts of angelica dahurica, 50 parts of turmeric, 45 parts of safflower, 50 parts of angelica, 50 parts of ligusticum wallichii, 50 parts of radix rehmanniae, 50 parts of fructus aurantii, 60 parts of earthworm, 60 parts of garden balsam.
3. The preparation method of the cancer-eliminating yang-strengthening paste as claimed in claim 1 or 2, wherein: the method comprises the following steps:
step one, weighing the raw materials of the component A according to the parts by weight of the raw materials, mixing, and grinding into 100-mesh fine powder to obtain powder A for later use;
step two, weighing and mixing the raw materials according to the weight parts of the raw materials of the component B to obtain a mixture; decocting the mixture with water twice, wherein the time for decocting with water is at least 1h each time; mixing the decoctions, and sieving with 100 mesh sieve to obtain filtrate; concentrating the filtrate into fluid extract for later use;
step three, weighing plaster matrixes, melting the plaster matrixes with slow fire, then removing the fire, cooling the plaster matrixes to 65-75 ℃, continuously stirring the plaster matrixes in the cooling process, slowly adding the fluid extract obtained in the step two, stirring the fluid extract uniformly, and then continuously heating the fluid extract with slow fire to remove water; and (3) cooling to 65-75 ℃ with fire, adding the powder A obtained in the step (I), and continuously stirring to spread paste to obtain the cancer-eliminating and yang-strengthening paste.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010363678.1A CN111437360A (en) | 2020-04-30 | 2020-04-30 | Cancer-eliminating yang-strengthening plaster |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010363678.1A CN111437360A (en) | 2020-04-30 | 2020-04-30 | Cancer-eliminating yang-strengthening plaster |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111437360A true CN111437360A (en) | 2020-07-24 |
Family
ID=71657916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010363678.1A Pending CN111437360A (en) | 2020-04-30 | 2020-04-30 | Cancer-eliminating yang-strengthening plaster |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111437360A (en) |
-
2020
- 2020-04-30 CN CN202010363678.1A patent/CN111437360A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103041317B (en) | A kind of Chinese medicine composition for the treatment of tumor and preparation method thereof | |
CN103356973A (en) | Antineoplastic traditional Chinese medicine | |
CN109010468A (en) | Antitumor Chinese and its preparation method and application based on ancient prescription Tuoli Xiaodu | |
CN104547939A (en) | Traditional Chinese medicine preparation for treating premature beat | |
CN104740583A (en) | Traditional Chinese medicine preparation for relieving Crohn's disease and preparation method for traditional Chinese medicine preparation | |
CN104721658A (en) | External plaster for treating cancer pain and preparation method thereof | |
CN105233188A (en) | Traditional Chinese medicine composition for treating liver cancer and application of traditional Chinese medicine composition | |
CN104623455A (en) | External application plaster for treating skeletal metastatic cancer pain and preparation method of external application plaster | |
CN111437360A (en) | Cancer-eliminating yang-strengthening plaster | |
CN105853866A (en) | Method for preparing Chinese herbal medicine composition for treating bedsore | |
CN105944031A (en) | Anti-radiation traditional Chinese medicine and preparation method | |
CN105561272A (en) | Traditional Chinese medicine preparation for relieving Reynolds disease and preparation method thereof | |
CN112494614A (en) | Chinese medicinal formula for preventing and treating cancer by using combination of pawpaw and various medicines | |
CN105213609A (en) | A kind of Chinese medicine composition for the treatment of decubital ulcer and preparation method thereof | |
CN105561098A (en) | Medicine for treating erosive beriberi | |
CN104623532A (en) | Traditional Chinese medicine composition for treating glioma and preparation method thereof | |
CN110856731A (en) | Traditional Chinese medicine external navel treatment ointment formula and preparation method thereof | |
CN115887601B (en) | A composition for treating hemorrhoid and its preparation method | |
CN109125450B (en) | Traditional Chinese medicine composition for treating psoriasis and application thereof | |
CN112535722B (en) | Traditional Chinese medicine composition and application thereof in preparation of medicine for treating fox hernia | |
CN102475875A (en) | Traditional Chinese medicine preparation for external use and preparation method thereof | |
CN106266548A (en) | The treatment Chinese medicine composition of chronic gastritis, preparation method and Chinese medicine preparation thereof | |
CN105687584A (en) | Traditional Chinese medicine for treating thyroid cancer and preparing method of traditional Chinese medicine | |
CN104352773A (en) | Traditional Chinese medicine preparation for treating chronic bronchitis and bronchial asthma | |
CN118078885A (en) | Externally applied medicine containing radix notoginseng for treating arthralgia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200724 |
|
WD01 | Invention patent application deemed withdrawn after publication |